Protein kinase C and phenylephrine induce comparable decrease in calcium sensitivity in skinned adult rat cardiac myocytes by Barta, Judit et al.
Cardiologia Hungarica 2011; 41 : 88–96
© 2011 Locksley Hall MediaOriginal article
Aims: The in vivo regulation of cardiomyocyte function by a1-adrenergic receptor agonist
phenylephrine (PE) has not been clarified yet. It has been suggested that PE acts partly via
protein kinase C (PKC)-mediated pathway. We aimed to compare the mechanism of action
of PE and PKC on myofilament function.
Methods: Isometric force and rate of force redevelopment (Ktr) were studied in adult rat
single permeabilized cardiomyocytes at various Ca2+ concentrations before and after
treatment with the catalytic subunit of PKC (PKC-M; 0.1 and 0.2 U/ml 40 min) and
after stimulation with PE. In order to reveal PKC-dependent phosphorylation of contractile
proteins two-dimensional gel electro phoresis was performed.
Results: PKC-M induced a dose-dependent decrease in Ca2+ sensitivity with DpCa50=
0.049±0.003 at low and DpCa50=0.089±0.005 at high activity. Respectively, similar
decreasing tendency was observed in maximal force (DFmax=16.5±2.8 and 21.2±2.3%), in
passive force (DFpas=7.6±6.6 and 38.6±6.6%), in myofilament cooperativity (DnHill=
0.40±0.06 and 0.96±0.19) and in Ktr (DKtr-Forcesslope=3.86±0.85 and 4.03±0.69). PE
treated cardiomyocytes also possessed decreased Ca2+ sensitivity (pCa50=5.68±0.01) compared to
controls (pCa50=5.77±0.02), but unlike PKC-M treated cells, myofilament cooperativity was
higher in the PE group (nHill=3.23±0.06) versus control group (nHill=2.89±0.10). There
was no significant change in maximal force, in passive force and in Ktr. Neither PKC-M nor PE
altered the phosphorylation status of a potential phosphorylation target, myosin light chain 2
(MLC-2).
Conclusion: The decrease in Ca2+ sensitivity following PE treatment is comparable to the
change observed after PKC-M administration. However the overall PKC-M effects were
more pronounced, probably because PKC-M mimics the effects of a wider range of PKC
isoforms than are activated during PE stimulation. MLC-2 phosphorylation plays no
potential role in this process.
A protein-kináz-C és a phenylephrin hasonló Ca2+-érzékenység csökke néshez
vezet izolált patkány szívizomsejteken
Célkitűzés: A szelektív a1-adrenerg receptor agonista phenylephrin (PE) myocardiumra
gyakorolt hatásáról keveset tudunk. Egyes feltételezések szerint a PE hatásai részben pro-
tein-kináz-C (PKC)-mediált szignáltranszdukciós útvonalon keresztül valósulnak meg.
Célkitűzésünk az volt, hogy összefüggést keressünk a PE és PKC miofilamentumokon meg-
valósuló hatásmechanizmusa között.
Módszerek: PKC katalitikus alegységgel (PKC-M; 0,1 és 0,2 U/ml 40 perc), illetve PE-
vel kezelt felnőtt patkány izolált permeabilizált szívizomsejteken vizsgáltuk a különböző
Ca2+-koncentráció jelenlétében generált izometrikus erőt és az erőgenerálódás kinetikáját
(Ktr). A kontraktilis fehérjék PKC-függő foszforilációjának vizsgálatára 2-dimenziós
gélelektroforézist végeztünk.
Eredmények: A PKC-M aktivitás-függő módon csökkentette a Ca2+-szenzitivitást,
DpCa50=0,049±0,003 volt alacsony, illetve DpCa50=0,089±0,005 magas aktivitás mel-
lett. Hasonlóan, aktivitásfüggő csökkenést mutatott a maximális erő (DFmax=16,5±2,8,
illetve 21,2±2,3%), a passzív erő (DFpas=7,6±6,6, illetve 38,6±6,6%), a miofilament
kooperativitás (DnHill=0,40±0,06, illetve 0,96±0,19) valamint a Ktr is (DKtr-Forces-
lope=3,86±0,85, illetve 4,03±0,69). A cardiomyocyták PE-vel történő kezelése is csökkent
Ca2+-érzékenységet (pCa50=5,68±0,01) eredményezett a kontrollhoz képest (pCa50=
5,77±0,02), azonban a PKC-M hatástól eltérően, PE hatására a miofilament kooperativ-
itás növekedett (nHill=3,23±0,06) a kontrollhoz viszonyítva (nHill=2,89±0,10). Ellen-
ben a maximális generált erő, a passzív erő és a Ktr nem változott szignifikánsan. Sem a
PKC-M sem a PE nem volt hatással a miozin könnyű lánc 2 (MLC-2) foszforilációs
állapotára, mely a PKC egyik potenciális foszforilációs targetje.
Következtetések: A PE hatására kialakuló Ca2+-érzékenység csökkenés hasonló ahhoz,
amit a PKC-M-kezelés indukál. Azonban a PKC-M hatásai összességében sokkal kife-
jezettebbek. Ennek egyik lehetséges magyarázata, hogy a PKC-M egyszerre több PKC izo-
forma hatását utánozza, mint amelyek PE stimulációkor aktiválódnak. Ebben a folyamat-
ban a MLC-2 foszforilációnak nincs szerepe.
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Introduction
Protein kinase C (PKC) in the heart has been impli -
cated in the regulation of force development via phos -
phorylation of cardiac contractile proteins and proteins
involved in calcium homeostasis and ion conductance
(1, 2). Mammalian PKC is a large family of Ser/Thr
protein kinases consisting of several isotypes encoded
by various genes (3). It has been hypothesized that the
individual isozymes may subserve distinct biological
function; however the precise mechanism by which
PKC affects cardiac myofibrillar function is ambi -
guous. Our knowledge on PKC-mediated contractile
changes in the heart is mainly based on in vitro expe -
riments using direct, non-specific cardiac PKC acti -
vator phorbol esters. 12-deoxyphorbol 13 isobu tyrate 20
acetate (DPBA) treatment led to a decrease in iso -
metric twitch force, in Ca2+ sensitivity and in nHill in
human trabeculae carneae (4), phorbol 12-myristate 13-
acetate (PMA) decreased the contractility of rat pa -
pillary muscle (5), but bovine brain PKC and 12-O-
tetradecanoylphorbol-13-acetate (TPA) induced a dec -
rease in maximal MgATPase activity without change
in Ca2+ sensitivity (6). Ward et al. (7) found both,
positive and negative inotropic effect after PMA
treatment depending on the PMA concentration in
Langendorff-perfused guinea pig hearts. Pi et al. (8)
reported increased Ca2+ sensitivity of isometric tension
and of ATPase activity with concomitant inhibition of
maximum ATPase rate in mouse heart. In human
skinned cardiac myocytes van der Velden et al. (9) have
shown decreased Ca2+ sensitivity after treatment with
the catalytic subunit of PKC (PKC-M), while maximal
force was not significantly altered. 
PKC activation has been directly demonstrated to
occur in response to a1-adrenergic stimulation (1,
10–15) and it has been observed that the enzyme is
translocated to the myofibrils (16). However, the role
of PKC in mediating the contractile changes of cardiac
muscle during alpha1-adrenergic stimulation presently
appears also controversial. a1-adrenoceptor stimulation
(i.e. phenylephrine (PE)) has been repeatedly shown to
exert positive inotropic effect (5, 12, 17–21) and to
increase myofilament Ca2+ sensitivity in skinned single
cardiac cells (22–25) and in intact muscle strips of rab-
bit (18). In contrast, others (26–29) found negative
inotropic effect in adult rat and mouse ventricular
cardiomyocytes due to PE stimulation. Pyle et al. (30)
reported decrease in maximal isometric tension and
stiffness in mouse papillary fiber boundles but no
change in Ca2+ sensitivity or nHill was observed.
Suematsu et al. (31) also failed to detect change in Ca2+
sensitivity in isolated canine cardiomyocytes. Further -
more, in skinned rat cardiomyocytes Strang et al. (32)
detected no change in maximal and resting tension in
addition to unchanged Ca2+sensitivity due to a1-
adrenergic stimulation. It is tempting to speculate that
upon PE exposition, changes in myofibrillar function
are attributable, at least in part, to PKC activation and
consecutive contractile protein phosphorylation. Car -
diac Troponin I (cTnI), cardiac Troponin T (cTnT) (9,
33, 34), ventricular myosin light chain-2 (MLC-2) (34),
and Myosin Bin ding Protein C (MyBPC) (6, 35) are
among the putative intracellular PKC targets but their
cue in regulating myofibrillar Ca2+ responsiveness is
obscure.
Based on the observations above, we designed a study
to compare the effects of the active PKC and a specific
receptor-mediated PKC activator PE on myofibrillar
Ca2+ responsiveness. PKC activity was mimicked by
treating single permeabilized cardiomyocytes from rat
hearts with the catalytic subunit of PKC (PKC-M).
PKC-M is no longer associated with the autoinhibitory
regulatory domain therefore is persistently active (36).
On the other hand, we tested whether consecutive
changes in myofibrillar protein phosphorylation takes
place during cell treatment; that is believed to par -
ticipate in the translation of signals upon PKC
activation.
Methods
Myocyte isolation
Adult male Wistar rats were used for the experiments.
The protocols were approved by the Committee of the
Ethics of Animal Experiments. To obtain mechanically
isolated left ventricular single cardiomyocytes the ani -
mals were anaesthetised with sodium pentobarbital (80
mg/kg ip.) and 1000 U heparine was added intra ve -
nously. The heart was quickly removed and perfused
with 2,3-butanedione monoxime (BDM)-containing
Ringer’s solution (in mM): MgCl2 1.2, CaCl2 1.0, KCl
4.8, NaCl 118, KH2PO4 2, pyruvate 5.0, glucose 11,
insuline 1, HEPES 25 (pH7.4), BDM 30. The left vent -
ricle was dissected and processed immediately as
described previously (37). 
During the isolation the tissue was kept on ice. To
remove all membranous struc tures and endogenous
kinases/phosphatases the myocytes were skinned at
room temperature by means of 0.3% Triton X-100 (5
minutes) and kept on ice until further use in isolating
relaxing solution containing (in mM): free Mg2+ 1,
KCl 145, EGTA 2, ATP 4, imidazole 10 (pH 7.0). In
case of enzymatically isolated myocytes, cells were
washed in oxygenated Ringer’s solution to get rid of
the Medium. 50% of the cells were saved for protein
analysis the rest was divided into two aliquots. The
cells were resus pended in oxygenated Ringer’s solution
(control group) or phenylephrine (10 µmol/l: Sigma)
and atenolol (1 µmol/l: ICN, ß-blocker) -containing
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oxygenated Ringer’s solution (PE-stimu lated group).
Both groups were incubated for 5 mi nutes at 37 °C
then quickly skinned at room tempe rature in 0.5%
Triton X-100-containing isolating relaxing solution (5
minutes) to preserve myofibrillar protein phos -
phorylation level. Cells were kept on ice until further
use.
Experimental protocol
Permeabilized cardiomyocytes were mounted in the
experimental set-up built on a Zeiss inverted micros -
cope as described (37). Briefly, a single myocyte was
attached between a force transducer and a piezoelectric
motor with silicon adhesive glue. Average sarcomere
length (SL) was 2.23±0.01 µm. The myocyte was
transferred from the mounting area to the stage of the
microscope and isometric force was measured by
transferring the cell from relaxing solution to activating
solutions at 15 °C. The composition of relaxing and
activating solutions was calculated as described by Papp
et al. (38). The pCa, i.e. –log10 [Ca
2+] of the relaxing and
maximal [Ca2+]activating solution were 9 and 4.5,
respectively. Solutions with subma xi mal Ca2+ con -
centration were obtained by mixing the maximal [Ca2+]
activating and relaxing solutions. Maximal active
isometric force per crossectional area was calculated
from difference between the zero force level and the
peak isometric force following correction for passive
force. Submaximal force values obtained at pCa>4.5
were normalised to the interpolated control (F0) values
measured at pCa4.5. Experiments were discarded if the
F0 at the end of the measurement was less than 80% of
F0 at the beginning of the expe riment, assuming a
linear decrease in maximal force with every activation.
Cells with a starting F0<20 kN/m
2 or a change in
sarcomere length during the experiment >0.2 µm were
also discarded. The rate constant of force rede velop -
ment (Ktr) was estimated using the slack test method as
described previously (39). Briefly, when the steady level
of force was developed in activating solution the
myocyte was rapidly slackened and re-stretched by 30%
of its length. Due to slacke ning the force drops to zero
and upon re-stretch force redevelopment occurs to the
initial steady level. The force redevelopment was fitted
with a single expo nential at pCa values from 4.5 to 5.6
At low Ca2+ concentration (pCa>5.6) force rede ve -
lopment could not be fitted accurately due to the low
signal-noise ratio.
The protocol was performed on 25 enzymatically-
isolated cells (control group n=11, PE group n=14) and
on 20 mechanically isolated cells (control and PKC-M).
After a first force-pCa series the mechanically isolated
cells were incubated on the set-up for 40 minutes at 20
°C in 6 mM DTT-containing relaxing solution with 0.1
or 0.2 U/ml PKC-M (Sigma P-1909 batch No.50K1178)
or without PKC-M (served as time control), n=7, n=9
and n=4 respectively. After incu bation the force
measurement protocol was repeated.
In vitro protein phosphorylation and 
Two-dimensional gel electrophoresis
Small pieces of rat left ventricular tissue (about 5 mm3)
were separated from the rat hearts used for mechanical
isolation and quickly frozen in liquid nitrogen and
freeze-dried at –80 °C. Tissue homogenate was made
in relaxing solution containing 500 µg/ml Pefabloc and
10 µl/ml Triton X-100, with 10 mg/ml total protein
concentration and incubated overnight at 4 °C.
Following centrifugation at 15 000 r/m for 10 minutes
at room temperature the pellet was resuspended in 500
µg/ml Pefabloc-containing relax and was centrifuged
again. The pellet was resuspended in relaxing solution
containing 500 µg/ml Pefabloc and 500 µg/ml Creatine
Phosphokinase, and was incubated together with 1
µl/500 µg protein Phosphatase Inhibitor Coctail I in the
presence of 2 or 4U/ml PKC or in the absence of PKC
at 20 °C for 60 minutes or at 37 °C for 120 minutes.
The reaction was stopped with adding 2D Sample
buffer. Samples (15 µg) were loaded on immobiline
strips with pH gradient of 4.5 to 5.5 (Amersham Phar -
macia Biotech). In the second dimension proteins were
separated by sodium dodecyl sulfate (SDS)-PAGE (40)
on gels with 12% total acrylamide concentration.
Proteins were visualised by silver staining (41). Gels
were analysed using Image Quant Software (Mole -
cular Dynamics) (42).
The phosphorylation status of MLC-2 of the control
and PE-stimulated enzymatically isolated cells was also
determined. Before loading the immobiline strips the
cells were treated with TCA to fixate the phos pho -
rylation status of the myofibrillar proteins immediately
after the stimulation protocol.
Untreated left ventricular rat tissue (directly frozen in
liquid nitrogen) served as reference sample.
Data analysis
Force-pCa relations were fitted by a non-linear fit
procedure to a modified Hill equation:
F (Ca2+)/F0 = [Ca
2+]nH/(Ca50
nH + [Ca2+]nH)
F is the steady state force, F0 denotes the steady force
at saturating [Ca2+], nH reflects the steepness of the
relationship, and Ca50 represents the midpoint of the
relation.
All values are presented as means±S.E.M. of n expe -
riments. Differences were tested by means of paired
Student’s t-test, unpaired Student’s t-test and
Mann–Whitney-test when applicable, P<0.05 was
chosen to indicate statistical significance.
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Results
Effect of PKC on force production
Force recordings at maximal (pCa 4.5) and at sub ma -
ximal (pCa 5.4) Ca2+ concentrations from perme a bi -
lized cardiomyocytes before and after PKC treatment
are shown in Fig.1. Initial maximal isometric tension
(Fmax), obtained at saturating Ca
2+ concentration was
41.9±3.5 kN/m2. Passive force per cross-sectional area
(Fpas), obtained in relaxing solution (pCa 9) amounted
to 2.1±0.1 kN/m2 (n=20). PKC treatment (0.1 U/ml,
n=7; 0.2 U/ml, n=9) resulted in a decrease in Fmax and
Fpas in an activity-dependent manner. As illustrated in
Fig. 2B, relative force development at maximal Ca2+
dropped to 83.5±2.8% and 78.8±2.3% after low dose
PKC (0.1 U/ml, closed circles) and high dose PKC (0.2
U/ml, closed squares), respectively. PKC treatment
decreased Fpas with 7.6±6.6% (0.1 U/ml) and 38.6±6.6%
(0.2 U/ml). The decrease was significant only at the
higher PKC activity.
Force-pCa relations were obtained by exposing the cells
to different Ca2+ concentrations. Data were fitted with
a modified Hill equation. The average force-pCa
relationship obtained before PKC incubation is shown
in panel A of Fig. 2. The steepness of the relation
(nHill) was amounted to 3.67±0.10. Ca2+ sensitivity of
force (pCa50) was 5.63±0.01. The recordings in Fig. 1
show that after PKC treatment the decline in force
development was even larger at submaximal Ca2+ than
at maximal Ca2+ concentration. In addition the steep -
ness was found to be decreased following incubation
with PKC, both at 0.1 and 0.2 U/ml PKC activity
(DnHill=0.40±0.06 and 0.96±0.20, respectively).
Indeed, upon 0.1 U/ml PKC incubation the curve was
significantly shifted to higher [Ca2+] (i.e. lower pCa)
(DpCa50=0.049±0.003), which indicates a decrease in
myofibrillar Ca2+ sensitivity. This decrease in Ca2+ sen -
si tivity was even more pronounced at higher PKC
activity (0.2 U/ml; DpCa50=0.089±0.005).
Since Fmax was decreased after PKC treatment, force
development at submaximal Ca2+ concentration should
be scaled for the decrease in Fmax. The resulting force-
pCa curves (Fig 2; panel B) reveal a marked decline in
Ca2+ responsiveness upon PKC.
The Ktr values obtained at pCa values ranging from 4.5
to 5.6 before and after PKC incubation are summari -
zed in panel C of Fig. 2. The low dose of PKC (0.1
U/ml) had no influence on the Ktr value measured at
pCa 4.5 and 5.6 but a decrease in Ktr was observed at
5.0, 5.2 and 5.4 (P<0.05). The high dose of PKC (0.2
U/ml) caused an overall decrease in Ktr regardless of
pCa. When plotted Ktr as a function of force at each
measured cell, an approximately linear relation was
found between Ktr and relative force (graph not
shown). Statistical analyses revealed a significant
decrease in the regression line of 0.1 U/ml PKC treated
myocytes (3.86±0.85). This decrease was even more
prominent at higher PKC activity (4.03±0.69).
In control experiments (n=4), when PKC was omitted
from the incubation medium, no significant change
was observed in any of the measured parameter
(DFmax=90.11±2.32%, DFpas=101.25±3.64%, DpCa50=
0.011±0.0025, DnHill=0.40±0.08, DKtr regr.=
1.24±0.51).
Effect of PE on force production
Enzymatically-isolated rat cardiomyocytes incubated in
Ringer without PE (control) or with PE (PE) were
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Figure 1. Isometric force development of mechanically isolated myocytes at maximal (A) and at
submaximal (B) Ca2+ concentration before and after incubation with PKC (0.2 U/ml). The abrupt
changes in force are due to the cell transfer from relaxing solution into activating solution and back.
The reduction in force when the steady state level had been reached is caused by the slack test (see
Methods) performed to measure the rate of force redevelopment (Ktr)
permeabilized, and force measurement and slack test
were performed (n=14 and 11; respectively).
Fmax did not differ significantly between the control
(40.7±4.5 kN/m2) and PE (41.2±3 kN/m2) group. In
addition no difference was found in Fpas between the
two groups (2.5±0.3 and 2.0±0.1 kN/m2 in control and
PE, respectively).
Average force-pCa curves are presented in the panel A
of Fig. 3. PE treatment shifted the force-pCa curve to
the right (pCa50=5.68±0.01), indicating that Ca
2+ sen -
sitivity of the PE myocytes was decreased compared to
controls (pCa50=5.77±0.02). The steepness of the curve
was slightly, though significantly higher in the PE
treated myocytes (3.23±0.06) than in the control cells
(2.89±0.10). It was shown previously that beta-blocker
alone does not alter Ca2+ sensitivity of iso metric force
(32, 43).
Ktr at high Ca
2+ concentration tended to be lower in PE
treated than in the control group, though not signi -
ficantly. However, at lower Ca2+ concentration (pCa
5.4 and 5.6) Ktr values were significantly lower in the
PE group (P<0.05) in comparison to the control group.
PKC and PE effect on protein phosphorylation
2D-gel electrophoresis and silver staining were per -
formed on rat tissue homogenates (untreated refe -
rence sample, Relax incubated and PKC treated
samples) and on a suspension of cardiomyocytes from
the control and the PE group.
Ventricular MLC-2 in the rat heart consists of two
isoforms (LC-2 and LC-2*), with the dominancy of
LC-2. Analyses of immediately TCA treated tissue
(reference sample) indicated that both LC-2 isoforms
were partly phosphorylated (LC-2P and LC-2*P) (panel
A and D of Fig. 4) under basal conditions. The
distribution of the isoforms was in %: LC-2: 48.1, LC-
2*: 10.8, LC-2P: 38.2 and LC-2*P: 2.9. The homo -
genate we used for the PKC experiments was
pretreated with Triton in relaxing solution overnight,
which shifted the isoform composition towards the
dephospho forms, LC-2*P was completely, while LC-
2P was almost completely dephosphorylated. PKC
treatment (2 U/ml) of the homogenate at 20 °C for 1
hour did not alter phosphorylation of the LC-2
isoforms (panel C and D) compared to control in -
cubation (panel B). Even if we increased PKC activity
to 4 U/ml, temperature to 37 °C and prolonged the
time of incubation to two hours, the phosphorylation
pattern was similar to the control incubations (panel B
and D).
Densitometric analyses of the 2D-gels from the Ringer
incubated and the PE treated cells are shown in panel
D. In the enzymatically isolated rat myocytes, incuba -
ted only in Ringer solution a low level of LC-2
phosphorylation remained as compared to basal LC-2
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Figure 2. (A) Isometric force-pCa relations of me -
cha nically isolated myocytes before (control;
n=20) and after treatment with PKC (0.1 and 0.2
U/ml, n=7 and 9 respectively). Data were fitted to
the mean values. Changes in Ca2+-sensitivity of
force arose 0.049±0.003 at low dose and
0.089±0.005 at high dose of PKC, the decrease in
steepness was 0.40±0.06 and 0.96±0.19, respec -
tively. (B) Force values of treated cells are given
as fractions of the last recorded maximal force at
saturating (Ca2+) immediately before PKC treat -
ment and of the maximal force obtained imme -
diately after PKC treatment. Absolute forces
were significantly lower following PKC
treatment in an activity-dependent manner
(P<0.05). Ktr values before and after PKC incu -
bation are indicated as a function of pCa (C).
Error bars visible only when larger than symbol
size
phosphorylation. PE stimulation did not induce LC-2
phosphorylation.
Discussion
Despite the increasing number of publications dis -
cussing the effect of PKC on myocardial function, our
knowledge in molecular understanding is incomplete.
In the present study we provide evidence that in rat
cardiomyocytes both PKC-M and the PKC activator
PE decrease the Ca2+ sensitivity of isometric force, to
similar extent. Since PKC-M and PE results in similar
decrease in Ca2+ sensitivity of force, we assume that
PE effects are mediated through PKC activation. PKC
effects rely on protein phosphorlyation. In our expe -
rimental setting, theoretically the active catalytic PKC
subunit directly can phosphorylate the accessible
substrates that can alter myocyte function, while upon
PE stimulation, PKC gets translocated to incompletely
defined intracellular target(s) also leading to protein
phosphorylation and change in myocyte function. The
phosphorylation of the following substrates is consi -
dered.
In many studies, PKC-mediated phosphorylation of
MLC-2 increased the Ca2+ sensitivity of force pro -
duction (44, 45), while others found no change in
Ca2+ sensitivity (6, 46) or even a decrease in Ca2+
sensitivity (24, 47). Since we showed by the analysis of
2D-gels, that MLC-2 phosphorylation by PKC-M or
during PE stimulation does not take place, the
contribution of MLC-2 phosphylation to the
decreased Ca2+ sensitivity of force can be ruled out in
our experimental settings. In a similar model of PKC
treated human cardio myocytes, Ca2+ sensitivity was
decreased without the phosphorylation of MLC-2 (9).
Holroyde et al. (48), High et al. (49) and Jeacocke et al.
(50) also failed to detect MLC-2 phosphorylation in
beating hearts following treatment with inotropic
agents. We have to discuss briefly a theory by
Andersen (5) and Suematsu (31), who suggested that
the PE effects are inde pendent from PKC activation
and depend on MLC kinase and Rho kinase. The
unchanged phospho ry lation level of MLC-2 indirectly
proves that the participation of MLCK or Rho kinase
in the PE-induced signal transduction pathway is not
very likely.
In additon to MLC-2, cTnI and cTnT are also putative
PKC targets. Exclusive (in vitro) cTnI phosphorylation
by PKC has been shown to inhibit maximal MgATPase
activity, or MgATPase Ca2+ sensitivity or it had dual
action depending on the PKC isoform and on the
phosphorylated site(s) of the substrate (6, 51, 52).
Others also demonstrated decrease in myofilament
Ca2+ sensitivity or in maximal tension (53). According
to Pi et al. (8) PKC itself decreases maximal ATPase
activity, increases Ca2+ sensitivity of ATPase activity
and of isometric tension but the functional conse -
quences of cTnI phosphorylation by PKC is dependent
on the phosphorylation status of the PKA sites.
Exclusive cTnT phosphorylation caused a decrease in
maximal tension, in Ca2+ sensitivity, in ATPase activity
and in cross-bridge cycling kinetics (46, 53–56).
Further more, cTnT seems to have a modulating role
on the functional effect of PKC-mediated phos pho -
rylation of cTnI when they are cophosphorylated (57).
cTnI-cTnT cophosphorylation inhibits maximal
MgATPase activity but has no effect on actomyosin
ATPase Ca2+ sensitivity (6, 44, 46, 55, 56). Van der
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Figure 3. (A) Force-pCa relations of control (Ringer, n=11) and PE treated (n=14) cells. Submaximal
forces were normalised to the maximal force measured at saturating [Ca2+] PE treatment significantly
decreased Ca2+ sensitivity (pCa50=5.69±0.01) versus control (pCa50=5.77±0.02) in enzymatically isolated
rat cardiomyocytes and caused a slight increase in nHill. pCa dependence of Ktr in the Ringer and the
PE group is shown in panel B. Values are expressed as Mean±S.E.M. Error bars are shown only when
larger than symbol size.
Velden et al. found cTnI and cTnT cophophorylation in
skinned PKC-M treated cardiomyocytes. We did not
check cTnI and cTnT phospho status, but it is possible
that the phosphylation of these two proteins took place
in our model as well, leading to the decreased Ca2+ sen -
sitivity.
MyBPC phosphorylation also has to be taken into
account. There is evidence that MyBPC does not
affect actomyosin ATPase activity (58), however
Venema et al. (6) came to the conclusion that MyBPC
has a dominant role in decreasing MgATPase actity. In
our model MyBPC phosphorylation was not tested, its
role in modifying myocyte function cannot be
excluded.
Our data is discordant considering the change in
maximal force, passive force, nHill and Ktr when
comparing PKC and PE groups. The catalytic subunit
of PKC developed decrease in maximal force, in
passive force, in nHill and in Ktr, whereas PE increased
nHill, the rest of the parameters were unchanged. This
difference does not mean that PE effects are not PKC-
mediated. We cannot expect general PKC effect and
specific, receptor–mediated PKC activation to be
equivalent. Adult cardiomyocytes express a set of PKC
isoforms, such as PKCa, PKCd, PKCe, and PKCz(13,
15, 59–61). The isofoms are believed to subserve
distinct biological functions. PE may preferentially
activate certain PKC isoforms (14, 15, 62) with dif -
ferent substrate specificity, while the catalytic subunit
of PKC we used in our study, lacks specificity of the
different PKC isoforms (36). PE has restriction in
activating PKC isoforms (53), eg. PKCa, PKCd and e
phosphorylates cTnI more than cTnT, while PKCz
works just opposite. PKCa phosphorylates Ser43/45 of
cTnI which leads to the decrease in maximal ATPase
activity while PKCd phosphorylates Ser23/24 and Ser43/45
at the same time as a hibrid of PKCa and PKA and
have dual actions, decreases maximal ATPase activity
via Ser43/45 and decreases Ca2+ sensitivity via Se23/24 (52).
PE may preferentially activate PKCe and PKCd (14, 15,
62). 
We also have to keep in mind that the functional
consequences of cTnI phosphorylation by PKC is
dependent on the phosphorylation status of the PKA
sites (8). PKC alone increases Ca2+ sensitivity of force
via phosphorylating its specific sites Ser43/45 and Thr144,
but if PKC crossphosphorylates the PKA sites (Ser23/24),
it can mask PKC effects on myofilament Ca2+ sensi -
tivity and the increase is abolished or a decrease in Ca2+
sensitivity occurs. It is generally known that during the
procedure of enzymatic cell isolation the proteins
become dephosphorylated as we found with LC-2
(Fig. 3). (Ringer group versus reference sample). If
cTnI is poorly phosphorylated, the PKA sites are
accessible for PKC.
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Figure 4. Silver stained 2D-gels (pH range 4.5-5.5, 12%
acrylamide gel) illustrate ventricular myosin light
chain 2 (LC-2) composition in untreated rat tissue
(A), in tissue incubated without and with PKC (B, no
PKC at 37 °C for 2 hours and C, 2 U/mL PKC at 20 °C
for 1 hour). Ventricular myosin light chain 2 isoforms
(LC-2 and LC-2*), which are both partly phos pho -
rylated (LC-2P and LC-2*P, respec tively) in untreated
tissue as shown in A and the corres pon ding densi -
tometric scan in the upper panel of D. The densi -
tometric scans shown in panel E indicate LC-2 phos -
phorylation level of tissue incubated in relaxing
solution for 1 hour at 20 °C or 2 hours at 37 °C (B) and
in Ringers’ solution (gel not shown). Incubation of
rat tissue with PKC did not increase LC-2 phos -
phorylation (C and E panel) nor did PE (F panel)
A
B
C
LC-2 LC-2* LC-2P LC-2*P
Considering the possible variations, we can speculate
that the overall PKC effect we found is the result of a
combined action of different PKC isoforms on various
substrates. This is supported by the fact that we found
similar changes in myocyte’s function as Gwathmey et
al. (4) did in human trabeculae carneae as a result of
PKC panactivation by DPBA. It is known that non -
physiological PKC activation does not mimic the effect
of DAG on PKC activation, which is generated
endogenously by a-stimulation (63). In deed, after PE
stimulation only the decrease in Ca2+ sensitivity was
consistently similar to the PKC incubation data.
Conclusion
Our data suggests that PE-induced changes in cardio -
myocyte function are mediated via PKC activation
since the decrease in Ca2+ sensitivity following PE
stimulation was comparable to the change observed
after PKC-M treatment. However, the overall PKC-M
effects were more pronounced, probably because
PKC-M mimics the effects of a wider range of PKC
isoforms with distinct substrate specificity than are
activated during PE stimulation. MLC-2 phospho -
rylation plays no potential role in this process.
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